top of page

IV Therapy NAD+

Continuous intravenous infusion therapy of nicotinamide adenine dinucleotide (NAD⁺)

1 h
10,000 Mexican pesos
Goldsmith

Service Description

Peripheral route. NAD⁺ is an essential coenzyme for energy production and DNA repair; the infusion is used as adjunctive support for fatigue, recovery, and cognitive clarity, without replacing prescribed medical treatments. It participates in redox reactions and as a substrate for sirtuins and PARPs, key for mitochondrial function and cellular repair.


Cancellation Policy

With your safety and the quality of service in mind, if you book a service requiring medical evaluation and our specialist determines you are not a candidate, we will apply your payment towards personalizing your service and experience to ensure the best possible results. Cancellations ● More than 14 days in advance: 100% refund of the deposit, or rescheduling at no cost. ● Between 7 and 14 days in advance: 50% refund of the deposit. ● Less than 7 days in advance or no-show: no refund; 100% of the deposit will be retained. ● If supplies have been purchased or prepared, additional charges may apply based on the actual cost of those materials. Lateness ● If the patient arrives more than 15 minutes late, Lonvida may: o Reduce the session duration, or reschedule the appointment according to the corresponding cancellation policy. ● When the delay results in the loss of prepared supplies, it will be considered as a cancellation without the right to a refund.


Contact Details

  • Goldsmith 38, Polanco, Polanco III Sección, Mexico City, CDMX, Mexico

    5579064445

    ventas@lonvida.com


Preguntas frecuentes

Lonvida-logo.png
  • Instagram
  • Facebook
  • LinkedIn
  • Youtube
  • TikTok

Contact

WA: +52 55 7906 4445

Tel: 55 9794 6262

USA: +1 608 400 0185

contacto@lonvida.com

Opening Hours

Monday to Friday

9:00 am - 6:00 pm

Saturday

9:00 am - 3:00 pm

Location

Goldsmith 38 – 3rd floor

Polanco, Mexico City.

Subscribe to our newsletter

London, 2025.

Health license: 25-TR-09-016-0001.

bottom of page